{
    "persona": "alt_right",
    "model": "llama2:70b-chat-q6_K",
    "topic": "healthcare",
    "language": "English",
    "text": "New study shows Atogepant significantly reduces migraine days for 70% of patients! 🤯💫🎉 Meaningful improvements were seen in just 13 weeks and maintained over 48 weeks! 💪🏼👍 It's time to give patients more options for effective migraine prevention.",
    "retrieved_source": "https://www.medscape.com/viewarticle/first-long-term-data-atogepant-migraine-prevention-2024a10007cb",
    "annotation": {
        "topic": null,
        "persona": null,
        "authenticity": null
    },
    "id": "adebd2a16b41c7550ac8a93c4be9a64a484849b7e1c3e561"
}